Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2031887
Max Phase: Preclinical
Molecular Formula: C51H78N14O13
Molecular Weight: 1095.27
Molecule Type: Protein
Associated Items:
ID: ALA2031887
Max Phase: Preclinical
Molecular Formula: C51H78N14O13
Molecular Weight: 1095.27
Molecule Type: Protein
Associated Items:
Canonical SMILES: CC(C)C[C@H](NC(=O)[C@H](C)N)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(N)=O
Standard InChI: InChI=1S/C51H78N14O13/c1-27(2)20-35(62-43(71)29(5)52)49(77)65-39(26-66)45(73)57-25-40(67)59-38(24-41(68)69)47(75)58-30(6)44(72)63-37(23-32-16-11-8-12-17-32)50(78)64-36(21-28(3)4)48(76)60-33(18-13-19-56-51(54)55)46(74)61-34(42(53)70)22-31-14-9-7-10-15-31/h7-12,14-17,27-30,33-39,66H,13,18-26,52H2,1-6H3,(H2,53,70)(H,57,73)(H,58,75)(H,59,67)(H,60,76)(H,61,74)(H,62,71)(H,63,72)(H,64,78)(H,65,77)(H,68,69)(H4,54,55,56)/t29-,30-,33-,34-,35-,36-,37-,38-,39-/m0/s1
Standard InChI Key: NWVVZPQOYGKQLK-AKTJGQIYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Protein | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1095.27 | Molecular Weight (Monoisotopic): 1094.5873 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Laurencin M, Legrand B, Duval E, Henry J, Baudy-Floc'h M, Zatylny-Gaudin C, Bondon A.. (2012) From a marine neuropeptide to antimicrobial pseudopeptides containing aza-β(3)-amino acids: structure and activity., 55 (5): [PMID:22320306] [10.1021/jm2011595] |
Source(1):